OppenheimerFunds’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $11.5M | Buy |
88,460
+68,180
| +336% | +$8.85M | 0.01% | 652 |
|
2018
Q4 | $2.35M | Sell |
20,280
-11,859
| -37% | -$1.37M | ﹤0.01% | 838 |
|
2018
Q3 | $3.45M | Sell |
32,139
-5,222
| -14% | -$560K | ﹤0.01% | 824 |
|
2018
Q2 | $3.19M | Buy |
37,361
+10,177
| +37% | +$868K | ﹤0.01% | 833 |
|
2018
Q1 | $2.1M | Sell |
27,184
-16,515
| -38% | -$1.28M | ﹤0.01% | 860 |
|
2017
Q4 | $3.69M | Buy |
43,699
+3,257
| +8% | +$275K | ﹤0.01% | 830 |
|
2017
Q3 | $3.46M | Buy |
40,442
+3,611
| +10% | +$309K | ﹤0.01% | 845 |
|
2017
Q2 | $3.03M | Buy |
36,831
+3,882
| +12% | +$319K | ﹤0.01% | 856 |
|
2017
Q1 | $2.77M | Sell |
32,949
-1,777
| -5% | -$149K | ﹤0.01% | 888 |
|
2016
Q4 | $2.55M | Sell |
34,726
-634,639
| -95% | -$46.7M | ﹤0.01% | 891 |
|
2016
Q3 | $53.7M | Buy |
669,365
+35,199
| +6% | +$2.83M | 0.07% | 299 |
|
2016
Q2 | $49.9M | Buy |
634,166
+63,096
| +11% | +$4.97M | 0.07% | 314 |
|
2016
Q1 | $41.1M | Sell |
571,070
-140,395
| -20% | -$10.1M | 0.05% | 363 |
|
2015
Q4 | $60M | Sell |
711,465
-6,606
| -0.9% | -$557K | 0.08% | 294 |
|
2015
Q3 | $60.1M | Buy |
718,071
+56,208
| +8% | +$4.7M | 0.08% | 292 |
|
2015
Q2 | $55.3M | Buy |
661,863
+83,553
| +14% | +$6.98M | 0.06% | 340 |
|
2015
Q1 | $42M | Buy |
578,310
+149,220
| +35% | +$10.8M | 0.05% | 409 |
|
2014
Q4 | $29.6M | Buy |
+429,090
| New | +$29.6M | 0.03% | 494 |
|